Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...
ZME Science on MSN
A new type of immunotherapy drug for prostate cancer shows up to 99% drop in cancer biomarkers
Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments ...
A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
The average age of men who get diagnosed is 67.
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...
The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...
The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award, which will ...
Prostate and skin cancers are among the most common cancers affecting men. In Advanced Prostate Cancer, lifelong treatment modalities are making a difference, challenges remain for patients with high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results